News
New names, new narratives: Why biotechs decide to rebrand
5+ hour, 27+ min ago (567+ words) Three recent examples illustrate just how different those transformations can be. While each company'emerged'with a new name and a new story to tell, the business realities behind those changes reveal three distinct approaches to reinvention.' Among the recent wave of…...
How VCs and universities can unlock stronger collaboration
2+ mon, 9+ hour ago (645+ words) The reality is at this early stage, the teams are just forming, and'it's'unclear what markets emerging technologies might have, and frankly,'that's'not what the researchers are here for. So,'I think there'is a little bit of a disconnect in end…...
Lisbon is calling: the BIO-Europe Startup Spotlight returns in March 2026
5+ mon, 4+ week ago (594+ words) The Startup Spotlight is BIO-Europe's high-profile pitch competition specifically designed for emerging and early-stage biotechs. This year, German startup Fusix Biotech, led by CEO Jennifer Altomonte, took home the trophy ahead of seven other finalists, confirming the persuasiveness of their…...
The 2025 AI biotech deals every executive should watch
7+ mon, 2+ week ago (841+ words) Along with receiving a $110 million upfront payment, CSPC is eligible to receive up to $1. 62 billion in potential development milestone payments and up to $3. 6 billion in sales milestone payments." According to Astra Zeneca, this collaboration further strengthens the big pharma's presence…...